Law Offices of Howard G. Smith announces an investigation on behalf of Treace Medical Concepts, Inc. (“Treace” or the “Company”) TMCI investors concerning the Company’s possible violations of federal securities laws.
On May 7, 2024, Treace released its first quarter 2024 financial results and revised its full year 2024 guidance, lowering it by approximately $20 million, citing “increased use of MIS Osteotomy solutions and more competition from knockoffs of [the Company’s] Lapiplasty products.”
On this news, Treace’s stock price fell $6.95, or 62.5%, to close at $4.17 per share on May 8, 2024, thereby injuring investors.
If you purchased Treace securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847 or by email to howardsmith@howardsmithlaw.com, or visit our website at www.howardsmithlaw.com.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241031901322/en/
Market News and Data brought to you by Benzinga APIs
